SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $608,000 | -58.9% | 1,143,140 | -1.2% | 0.00% | -66.7% |
| Q2 2023 | $1,479,000 | -18.0% | 1,156,865 | +12.2% | 0.00% | -25.0% |
| Q1 2023 | $1,804,000 | -44.3% | 1,031,132 | +0.0% | 0.00% | -42.9% |
| Q4 2022 | $3,236,000 | -42.6% | 1,030,958 | -11.3% | 0.01% | -53.3% |
| Q3 2022 | $5,640,000 | +17.8% | 1,161,925 | -0.5% | 0.02% | +25.0% |
| Q2 2022 | $4,789,000 | -22.3% | 1,167,533 | +10.2% | 0.01% | -14.3% |
| Q1 2022 | $6,167,000 | -13.6% | 1,059,517 | +12.3% | 0.01% | -12.5% |
| Q4 2021 | $7,138,000 | +2505.1% | 943,816 | +3023.6% | 0.02% | +1500.0% |
| Q3 2021 | $274,000 | -34.9% | 30,216 | -14.4% | 0.00% | 0.0% |
| Q2 2021 | $421,000 | +0.7% | 35,296 | +5.5% | 0.00% | 0.0% |
| Q1 2021 | $418,000 | -27.7% | 33,441 | -9.6% | 0.00% | -50.0% |
| Q4 2020 | $578,000 | +57.1% | 36,985 | -4.5% | 0.00% | 0.0% |
| Q3 2020 | $368,000 | +1.1% | 38,735 | -4.9% | 0.00% | 0.0% |
| Q2 2020 | $364,000 | +29.5% | 40,731 | -35.7% | 0.00% | 0.0% |
| Q1 2020 | $281,000 | -13.8% | 63,373 | +20.5% | 0.00% | 0.0% |
| Q4 2019 | $326,000 | -33.2% | 52,601 | -8.6% | 0.00% | -33.3% |
| Q3 2019 | $488,000 | -6.7% | 57,576 | +18.3% | 0.00% | 0.0% |
| Q2 2019 | $523,000 | +17.5% | 48,655 | +4.4% | 0.00% | 0.0% |
| Q1 2019 | $445,000 | -44.7% | 46,605 | -34.8% | 0.00% | -50.0% |
| Q4 2018 | $805,000 | -48.6% | 71,516 | -24.2% | 0.01% | -45.5% |
| Q3 2018 | $1,565,000 | +358.9% | 94,316 | +292.1% | 0.01% | +266.7% |
| Q2 2018 | $341,000 | +43.9% | 24,055 | +93.9% | 0.00% | +50.0% |
| Q1 2018 | $237,000 | +17.9% | 12,405 | +0.8% | 0.00% | 0.0% |
| Q4 2017 | $201,000 | +1.5% | 12,305 | -6.1% | 0.00% | 0.0% |
| Q3 2017 | $198,000 | -23.6% | 13,105 | -55.4% | 0.00% | 0.0% |
| Q2 2017 | $259,000 | +25.7% | 29,405 | -25.4% | 0.00% | 0.0% |
| Q1 2017 | $206,000 | +71.7% | 39,405 | +0.3% | 0.00% | +100.0% |
| Q4 2016 | $120,000 | -16.7% | 39,305 | +26.8% | 0.00% | -50.0% |
| Q3 2016 | $144,000 | -19.1% | 31,005 | +1.3% | 0.00% | 0.0% |
| Q2 2016 | $178,000 | -7.8% | 30,605 | -4.7% | 0.00% | +100.0% |
| Q1 2016 | $193,000 | +3.2% | 32,105 | +56.6% | 0.00% | -50.0% |
| Q4 2015 | $187,000 | +70.0% | 20,505 | +5.1% | 0.00% | +100.0% |
| Q3 2015 | $110,000 | -24.1% | 19,505 | +48.9% | 0.00% | -50.0% |
| Q2 2015 | $145,000 | -6.5% | 13,102 | +28.5% | 0.00% | 0.0% |
| Q4 2014 | $155,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |